Newborn with SMA gene mutation receives presymptomatic treatment at SAT Hospital, a rare step in managing rare diseases.

DataM Intelligence | competitive Intelligence Spinal Muscular Atrophy treatment is evolving fast, with gene therapy, oral drugs, and next-g ...

Research teams funded by the National Institutes of Health (NIH) have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord ...

His father had undiagnosed ataxia. Examination showed ataxia and pyramidal signs. Brain MRI: olivopontocerebellar atrophy; spine MRI: global spinal cord atrophy (Figure). Genetic test confirmed ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

People with spinal muscle atrophy (SMA), an inherited neuromuscular disease, usually experience muscle weakness that impacts movement. New research suggests that electrical spinal cord stimulation ...

First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy. Nature Medicine , 2025; DOI: 10.1038/s41591-024-03484-8 Cite This Page : ...

titled “First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy.” In their paper, the team noted, “In summary, our results provide insights into ...

However, the majority of serial studies have failed to find a correlation between spinal cord atrophy and disability. Objectives: To use a highly reproducible and accurate method to quantify spinal ...

Spinal muscular atrophy, SMA, a genetic neuromuscular disorder with progressive muscle wasting due to mutation in the SMN1 gene, deficiency in SMN protein, and loss of motor neurons, 3D illustration ...

Adult-onset spinal muscular atrophy (SMA) is a rare neuromuscular disorder that primarily affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. SMA is part of a ...